Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clever Leaves Holdings Inc (NQ: CLVRW )

N/A UNCHANGED
Last Price Updated: 3:56 PM EDT, May 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Clever Leaves Holdings Inc

Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) reported its financial results late Monday for the fourth quarter and full year concluded on December 31, 2023.  
Via Benzinga
Topics Cannabis
Exposures Cannabis
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
The European cannabis market is one of the most rapidly expanding markets globally.Prohibition Partners revealed in its latest report on cannabis in Europe that the combined market size of all CBD... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Clever Leaves Holdings Inc. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Colombia's President Wants Weed Legalized Despite Senate Opposition: Prohibition Increases 'Profits Of Drug Trafficking, Violence'
The Colombian Senate has put on hold a measure seeking to legalise marijuana, despite it having advanced through the Chamber of Representatives and a Senate committee. Colombian President Gustavo Petro... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Clever Leaves Fights Back: Bold Moves Secure Its NASDAQ Position Amid Global Cannabis Market Uncertainties
Amid challenges faced by the global cannabis market, Clever Leaves Holdings (NASDAQ: CLVR) (NASDAQ: CLVRW) has made a decisive move to maintain its listing on the 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Clever Leaves Shares Trading Higher On Its Colombian Cannabis Launching In Australia
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced that its Colombian flower is now available to patients in Australia through a partnership with Australian Natural Therapeutics G 
Via Benzinga
Clever Leaves Sells Cannabis Processing Facility In Portugal To Curaleaf's Subsidiary
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) has closed the sale of the assets, including lab and processing equipment, previously used in its EU-GMP certified cannabis processing 
Via Benzinga
Clever Leaves Teams Up With SOMAÍ Pharma., Completes First CBD Extract Shipments To Portugal
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GM 
Via Benzinga
Clever Leaves' Q1 Net Loss Drops Significantly After Operating Expenses Slashed By 48%
Global medicinal cannabis company Clever Leaves Holdings Inc. 
Via Benzinga
Clever Leaves Teams Up With Hypera Pharma To Supply CBD-Dominant Oral Solutions For Brazilian Patients
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NADAQ:CLVRW) has entered into a five-year agreement with Hypera Pharma (B3:HYPE3) to supply Clever Leaves’ CBD-dominant oral solutions with the aim of... 
Via Benzinga
Clever Leaves And Praetorian Team Up To Produce Cannabis Genetics In Colombia
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced its commercial agreement with US-based Praetorian Global Inc., to produce cannabis flower and downstream products from Clever... 
Via Benzinga
Cannabis Operator Makes Extremely Difficult Decision To Lay Off 63 Employees For Expected Savings Of $7M
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced the wind-down of all operations in Portugal as part of its ongoing restructuring initiatives. 
Via Benzinga
Clever Leaves Q3 Revenue Declines 18% YoY, Provides Outlook
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) Q3 2022 revenue was $3.3 million, a 18% decrease compared to $4.0 million in Q3 2021. 
Via Benzinga
Clever Leaves To Bring Its THC Dominant Oral Solution To Peru Via Partnership With Anden Naturals
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced that its partner, Peruvian medicinal cannabis company Anden Naturals, has obtained the sanitary registration 
Via Benzinga
Clever Leaves To Grow & Commercialize House Of Kush THC Flower For International Cannabis Markets
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) entered into partnership with House of Kush, to be the exclusive grower and distributor of proprietar 
Via Benzinga
Cannabis Company Sannabis Partners With Occupational Health Services Provider In Colombia
Sannabis S.A.S., a licensed Colombian cannabis company being acquired by Ultimate Sports, Inc. (OTCPK:USPS), a men’s health services provider in the U.S., entered into an agreement with Human Fine, an... 
Via Benzinga
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies. 
Via Benzinga
Clever Leaves 2Q: Neutraceuticals Up, Preparing For Cannabis Flower Exports From Colombia
The Analyst 
Via Benzinga
Improving Balance Sheet Is Paying Off For Clever Leaves, Q2 Revenue Grows 27% YoY
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) released financial results for the second quarter ended June 30, 2022, revealing revenue increased 27% to $4.7 million compared to $3.7... 
Via Benzinga
Clever Leaves To Ship First Export Of Cannabis To Israeli Partner InterCure
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) will ship the first commercial export to Israel of high THC flower for medical use from its facility in Portugal through its partnership with... 
Via Benzinga
Cantourage And Clever Leaves Intensify Partnership For Distribution Of Medical Cannabis In Germany
Cantourage GmbH and Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) have continued to intensify their strategic partnership for the distribution of medical cannabis flowers throughout... 
Via Benzinga
Clever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2M
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and... 
Via Benzinga
Clever Leaves Affiliate Now Fully Licensed To Distribute Medical Cannabis In Germany
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) and its affiliate in Germany, Clever Leaves Germany GmbH, have received all of the required regulatory licenses, per 
Via Benzinga
Clever Leaves Partners With Biom Therapeutics As Supplier Of Pharmaceutical-Grade CBD Used In Clinical Trials
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), announced a two-year supply agreement with American, clinical-stage bio-pharmaceutical company, Biom Therapeutics to provide 
Via Benzinga
Why Is Clever Leaves Stock Surging 140%? Look To Washington DC Next Week For The Answer
Stocks of Clever Leaves Holdings Inc. (NASDAQ:CLVRW)... 
Via Benzinga
Clever Leaves Reports Fourth Quarter And Full Year 2021 Results
Clever Leaves Holdings Inc. (NASDAQ:CLVRW), a leading mul... 
Via Benzinga
InterCure And Clever Leaves Enter Into International Strategic Partnership
InterCure Ltd. (NASDAQ:INCR) (TSX: 
Via Benzinga
The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign
Below is a recap of the main news related to the cannabis industry and markets for the week of November 8, 2021. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Clever Leaves Reports Third Quarter 2021 Results, Continues Expansion
Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ: 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.